Stock listing
Elicera Therapeutics Ab
Selected listing: ELIC · OMXSTO · SEK · SE
Elicera Therapeutics Ab (Stockholm:ELIC), Health Technology. Latest release Jun 1, 2026: Elicera announces outcome of the rights issue.
- Ticker
- Stockholm:ELIC
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Stockholm
- Currency
- SEK
About Elicera Therapeutics Ab
Elicera Therapeutics AB is a public company traded under the ticker ELIC on the Swedish market. Elicera focuses on developing innovative therapies in the field of cancer treatment.
Latest news from Elicera Therapeutics Ab
Elicera announces outcome of the rights issue
June 1, 2026
Elicera Therapeutics announces that the final reporting and final payment from the EIC Accelerator for the CARMA study have been approved
May 25, 2026
Elicera publishes information document regarding the rights issue
May 11, 2026
Elicera Therapeutics carries out a rights issue of approximately SEK 73 million
April 21, 2026
Elicera Therapeutics receives Notice of Allowance for Japanease patent protecting the ELC-401 CAR T-cell candidate
March 11, 2026
Research Elicera Therapeutics Ab
Elicera Therapeutics Ab company profile
View the public company page for Elicera Therapeutics Ab on 6ix.
Elicera Therapeutics Ab news
Read company news and market updates connected to Elicera Therapeutics Ab.
Elicera Therapeutics Ab investor events
Find investor webinars, events, and replay context for Elicera Therapeutics Ab.
Alternate listings
8E8:FWB
DE · EUR
Alternate listing for Elicera Therapeutics Ab; the primary context on this page is ELIC:OMXSTO.
8E8:GETTEX
DE · EUR
Alternate listing for Elicera Therapeutics Ab; the primary context on this page is ELIC:OMXSTO.
8E8:MUN
DE · EUR
Alternate listing for Elicera Therapeutics Ab; the primary context on this page is ELIC:OMXSTO.
ELICBTA:OMXSTO
SE · SEK
Alternate listing for Elicera Therapeutics Ab; the primary context on this page is ELIC:OMXSTO.